Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four ‘newly adopting’ countries

This publication has 12 references indexed in Scilit:

• Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use
  The Lancet, 1997
• Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants
  The Lancet, 1997
• Prospects for the use of new vaccines in developing countries: cost is not the only impediment
  Vaccine, 1996
• Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections
  The Pediatric Infectious Disease Journal, 1996
• A framework for the evaluation of vaccines for use in the expanded programme on immunization
  Vaccine, 1994
• The Efficacy in Navajo Infants of a Conjugate Vaccine Consisting ofHaemophilus influenzaeType b Polysaccharide andNeisseria meningitidisOuter-Membrane Protein Complex
  New England Journal of Medicine, 1991
• Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children
  The Pediatric Infectious Disease Journal, 1991
• A population-based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, Chile
  The Pediatric Infectious Disease Journal, 1990
• HAEMOPHILUS INFLUENZAE TYPE b DISEASE IN AN ARAB GULF STATE
  The Pediatric Infectious Disease Journal, 1989
• Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in Infancy
  New England Journal of Medicine, 1987